vinpocetine has been researched along with Eye Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cuşnir, R; Cuşnir, V; Dumbravă, V; Midrigan, I; Slepova, O; Zaiţeva, N | 1 |
Bönöczk, P; Cserjés, Z; Kiss, G; Szikszay, E; Végh, S | 1 |
Alberth, B; Somogyi, E | 1 |
3 other study(ies) available for vinpocetine and Eye Diseases
Article | Year |
---|---|
[Ocular manifestations of hepatitis B].
Topics: Adolescent; Adult; Case-Control Studies; Cataract; Conjunctiva; Disease Progression; Eye Diseases; Female; Hepatitis B; Humans; Limbic System; Male; Middle Aged; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 1997 |
[Retrospective analysis of the effect of vinpocetine infusion in ophthalmologic disorders].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Diabetic Retinopathy; Eye Diseases; Female; Humans; Infusions, Intravenous; Macular Degeneration; Male; Middle Aged; Myopia; Ocular Hypertension; Optic Neuropathy, Ischemic; Retinitis Pigmentosa; Retrospective Studies; Time Factors; Treatment Outcome; Vinca Alkaloids; Vision Disorders; Vision, Ocular; Visual Fields | 2006 |
Observations with Cavinton (RGH-4405).
Topics: Adolescent; Adult; Aged; Eye Diseases; Female; Humans; Male; Middle Aged; Vasodilator Agents; Vinca Alkaloids | 1979 |